Samsara BioCapital
North America, California, United States, Palo Alto
Description
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies.
Investor Profile
Samsara BioCapital has made 147 investments, with 20 in the past 12 months and 12% as lead.
Stage Focus
- Series B (29%)
- Post Ipo Equity (24%)
- Series A (20%)
- Series C (14%)
- Series D (5%)
- Series Unknown (4%)
- Seed (2%)
- Series E (1%)
- Undisclosed (1%)
Country Focus
- United States (86%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (4%)
- France (1%)
- China (1%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Switzerland (1%)
- Germany (1%)
- Denmark (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Life Science
- Biopharma
- Health Diagnostics
- Information Technology
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
